Patents by Inventor Suman Paul

Suman Paul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124608
    Abstract: This document relates to methods and materials for treating T cell cancers. For example, a composition containing one or more bispecific molecules targeting T cell receptor £ chain constant region (TRBC) can be administered to a mammal having a T cell cancer to treat the mammal. For example, this document provides methods and materials for using one or more bispecific molecules to treat a mammal having a T cell cancer.
    Type: Application
    Filed: February 15, 2022
    Publication date: April 18, 2024
    Inventors: Michael S. Hwang, Kenneth W. Kinzler, Brian J. Mog, Nickolas Papadopoulos, Andrew M. Pardoll, Suman Paul, Bert Vogelstein, Shibin Zhou
  • Patent number: 11926642
    Abstract: The invention relates to compounds of formula I wherein R1, R2 and - - - - - are as defined herein, pharmaceutical compositions comprising the compounds and methods of treating COVID-19 in a patient by administering therapeutically effective amounts of the compounds and methods of inhibiting or preventing replication of SARS-CoV-2 with the compounds.
    Type: Grant
    Filed: July 1, 2021
    Date of Patent: March 12, 2024
    Assignee: Pfizer inc.
    Inventors: Robert Steven Kania, Padmavani Bezawada, Emma Louise Hawking, Rohit Jaini, Samir Kulkarni, Matthew Nathan O'Brien Laramy, Jonathan Richard Lillis, Suman Luthra, Dafydd Rhys Owen, Klimentina Dimitrova Pencheva, Anil Mahadeo Rane, Matthew Forrest Sammons, Bradley Paul Sullivan, Andrew John Thiel, Martyn David Ticehurst, Jamison Bryce Tuttle, Robert Louis Hoffman
  • Publication number: 20240002541
    Abstract: This document relates to methods and materials for treating T cell cancers. For example, a composition containing one or more bispecific molecules can be administered to a mammal having a T cell cancer to treat the mammal. For example, methods and materials for using one or more bispecific molecules to treat a mammal having a T cell cancer are provided.
    Type: Application
    Filed: December 1, 2021
    Publication date: January 4, 2024
    Inventors: Sarah DiNapoli, Jacqueline Douglass, Emily Han-Chung Hsiue, Michael S. Hwang, Kenneth W. Kinzler, Maximilian Konig, Brian J. Mog, Nickolas Papadopoulos, Andrew M. Pardoll, Suman Paul, Alexander H. Pearlman, Bert Vogelstein, Shibin Zhou